A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralization | Science Translational Medicine
A cocktail of antibodies binding the fusion and receptor binding proteins of Nipah and Hendra viruses provides protection and resilience to resistance.
